Twister Biotech was created around the break-through and disruptive platform technology, MiniVectors, that originated in the laboratory of Dr. Lynn Zechiedrich at Baylor College of Medicine. MiniVectors are supercoiled DNA minicircles containing ONLY the sequence of interest, as small as a few hundred base pairs, compared to traditional plasmids that are orders of magnitude larger. Experiments have demonstrated that MiniVectors are a safe and effective platform for getting DNA into “difficult-to-transfect” cells, such as primary and stem cells. Twister’s primary mission is to provide MiniVectors to researchers to enable better transfection efficiencies and allow longer-term effects to be observed.